Codeine-6-glucuronide

Codeine-6-glucuronide
Names
IUPAC name
(5α,6α)-3-methoxy-17-methyl-7,8-didehydro-4,5-epoxymorphinan-6-yl β-D-glucopyranosiduronic acid
Identifiers
3D model (Jmol) Interactive image
ChemSpider 4590054
PubChem 5489029
Properties
C24H29NO9
Molar mass 475.49 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Codeine-6-glucuronide (C6G) is a major active metabolite of codeine and may be responsible for as much as 60% of the analgesic effects of codeine. C6G exhibits decreased immunosuppressive effects compared to codeine.[1] During its metabolism, codeine is conjugated with glucuronic acid by the enzyme UDP-Glucuronosyltransferase-2B7 (UGT2B7) to form codeine-6-glucuronide.[2][3]

See also

References

  1. Srinivasan, V.; Wielbo, D.; Tebbett, I. R. (1997). "Analgesic effects of codeine-6-glucuronide after intravenous administration". European Journal of Pain. 1 (3): 185–190. doi:10.1016/S1090-3801(97)90103-8. PMID 15102399.
  2. Vree, T. B.; Van Dongen, R. T.; Koopman-Kimenai, P. M. (2000). "Codeine analgesia is due to codeine-6-glucuronide, not morphine". International journal of clinical practice. 54 (6): 395–398. PMID 11092114.
  3. Armstrong, S. C.; Cozza, K. L. (2003). "Pharmacokinetic Drug Interactions of Morphine, Codeine, and Their Derivatives: Theory and Clinical Reality, Part II". Psychosomatics. 44 (6): 515–520. doi:10.1176/appi.psy.44.6.515. PMID 14597688.


This article is issued from Wikipedia - version of the 8/29/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.